XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Note 3 - Earnings Per Share ("EPS") | 9 Months Ended
--- | ---
Jan. 29, 2022
Notes to Financial Statements |
Earnings Per Share [Text Block] | Note 3. Earnings Per Share ("EPS") The following is a reconciliation of the net income and common share amounts used in the calculation of basic and diluted EPS for the three and nine months ended January 29, 2022 and January 30, 2021:
|  | Net (loss) income |  |  | Shares |  |  | Per share (loss) income |
For the three months ended January 29, 2022 |  |  |  |  |  |  |  |  |  |  |  |
Basic (loss) earnings per share |  | $ | (4,350 | ) |  |  | 45,223 |  |  | $ | (0.10 | )
Dilution associated with stock compensation plans |  |  | — |  |  |  | — |  |  |  | — |
Diluted (loss) earnings per share |  | $ | (4,350 | ) |  |  | 45,223 |  |  | $ | (0.10 | )
For the three months ended January 30, 2021 |  |  |  |  |  |  |  |  |  |  |  |
Basic (loss) earnings per share |  | $ | (214 | ) |  |  | 45,064 |  |  | $ | (0.00 | )
Dilution associated with stock compensation plans |  |  | — |  |  |  | — |  |  |  | — |
Diluted (loss) earnings per share |  | $ | (214 | ) |  |  | 45,064 |  |  | $ | (0.00 | )
For the nine months ended January 29, 2022 |  |  |  |  |  |  |  |  |  |  |  |
Basic earnings per share |  | $ | 1,709 |  |  |  | 45,263 |  |  | $ | 0.04 |
Dilution associated with stock compensation plans |  |  | — |  |  |  | 179 |  |  |  | — |
Diluted earnings per share |  | $ | 1,709 |  |  |  | 45,442 |  |  | $ | 0.04 |
For the nine months ended January 30, 2021 |  |  |  |  |  |  |  |  |  |  |  |
Basic earnings per share |  | $ | 10,669 |  |  |  | 44,908 |  |  | $ | 0.24 |
Dilution associated with stock compensation plans |  |  | — |  |  |  | 153 |  |  |  | — |
Diluted earnings per share |  | $ | 10,669 |  |  |  | 45,061 |  |  | $ | 0.24 |
Options outstanding to purchase 2,216 shares of common stock with a weighted average exercise price of $8.17 for the three months ended January 29, 2022 and 2,337 shares of common stock with a weighted average exercise price of $8.70 for the three months ended January 30, 2021 were not included in the computation of diluted earnings per share because the effects would be anti-dilutive. Options outstanding to purchase 1,857 shares of common stock with a weighted average exercise price of $9.26 for the nine months ended January 29, 2022 and 2,268 shares of common stock with a weighted average exercise price of $9.29 for the nine months ended January 30, 2021 were not included in the computation of diluted earnings per share because the effects would be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration